CHAO CHENG to Tumor Microenvironment
This is a "connection" page, showing publications CHAO CHENG has written about Tumor Microenvironment.
Connection Strength
4.006
-
The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma. Mol Cancer. 2024 Sep 04; 23(1):185.
Score: 0.644
-
TimiGP: An R package to depict the tumor microenvironment from bulk transcriptomics. STAR Protoc. 2023 12 15; 4(4):102742.
Score: 0.611
-
TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs. Cell Rep Med. 2023 07 18; 4(7):101121.
Score: 0.596
-
Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment. Sci Rep. 2019 12 03; 9(1):18257.
Score: 0.463
-
Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs. Cancer Res. 2018 11 15; 78(22):6413-6423.
Score: 0.427
-
Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment. Cancer Res. 2017 03 15; 77(6):1271-1282.
Score: 0.380
-
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood Cancer J. 2024 03 06; 14(1):38.
Score: 0.156
-
A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma. Br J Cancer. 2022 11; 127(9):1691-1700.
Score: 0.140
-
A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. Genome Med. 2022 01 12; 14(1):5.
Score: 0.134
-
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy. Clin Cancer Res. 2020 06 15; 26(12):2908-2920.
Score: 0.117
-
Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Cancer Immunol Res. 2019 07; 7(7):1079-1090.
Score: 0.111
-
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med. 2018 03 05; 215(3):895-910.
Score: 0.102
-
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Nat Commun. 2024 Feb 08; 15(1):1199.
Score: 0.039
-
Predicting clinical outcomes of cancer patients with a p53 deficiency gene signature. Sci Rep. 2022 01 25; 12(1):1317.
Score: 0.034
-
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J. 2019 02; 33(2):1644-1657.
Score: 0.027
-
VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival. Cancer Immunol Immunother. 2018 Jul; 67(7):1113-1121.
Score: 0.026